Search - tctmd.com

Displaying 441 - 460 of 586

Sort: Relevancy | Date

Presentation TCT 2012

Is Intraaortic Balloon Counterpulsation Really Useful in Cardiogenic Shock? Results of the IABP-SHOCK II Trial

Presenter: Holger Thiele

October 25, 2012

Presentation TCT 2012

Hypothermia in STEMI: When, to Whom, and How? (Cardiac Arrest, Cardiogenic Shock, Stable STEMI)

Presenter: Michael Mooney

October 25, 2012

Presentation TCT 2012

Glycoprotein IIb/IIIa Inhibitors in the Era of Bivalirudin and New Oral Antiplatelet Agents: Is Intracoronary Application the Standard of Choice?

Presenter: Rajesh Dave

October 25, 2012

Presentation TCT 2012

Geographic Disparities in the Management of ACS in the United States: Making the Case for Standardization of Care

Presenter: Yele Aluko

October 25, 2012

Presentation TCT 2012

Debate: Yes to Routine Thrombectomy in STEMI: New Trials Are Not Needed!

Presenter: Giuseppe De Luca

October 25, 2012

Presentation TCT 2012

Debate: Transradial Access Should Be the Default Access Site in STEMI Patients!

Presenter: Jennifer Tremmel

October 25, 2012

Presentation TCT 2012

Debate: Transfemoral Access Should Be the Default Access Site in STEMI Patients!

Presenter: Michael Haude

October 25, 2012

Presentation TCT 2012

Debate: Primary PCI Is the Default Reperfusion Method Irrespective of Time to Transfer!

Presenter: Cindy Grines

October 25, 2012

Presentation TCT 2012

Debate: No to Routine Thrombectomy in STEMI: Still Yet to Be Demonstrated!

Presenter: Sanjit Jolly

October 25, 2012

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

Presentation TCT 2012

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Roxana Mehran

October 25, 2012

Presentation TCT 2012

A Prospective, Randomized Trial of Post-Conditioning in Patients with ST-Segment Elevation Myocardial Infarction

Presenter: Joo-Yong Hahn

October 25, 2012

Presentation TCT 2012

TRILOGY ACS Angiographic Cohort: A Prospective, Randomized Trial of Prasugrel vs. Clopidogrel in Patients with Non-ST-Segment Elevation ACS Who Are Medically Managed After...

Presenter: Stephen Wiviott

October 24, 2012

Presentation TCT 2012

To Stage or Not to Stage?

Presenter: Philippe Genereux

October 24, 2012

Presentation TCT 2012

The Potential of Otamixaban as a Procedural Anticoagulant

Presenter: Philippe Steg

October 24, 2012

Presentation TCT 2012

Systemic Hypothermia: For Hospital Arrest and Myocardial Infarction?

Presenter: Goran Olivecrona

October 24, 2012

Presentation TCT 2012

Strategies for the ACS Patient with Chronic Atrial Fibrillation

Presenter: C. Michael Gibson

October 24, 2012

Presentation TCT 2012

STEMI Cocktails

Presenter: Shamir Mehta

October 24, 2012

Presentation TCT 2012

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Presenter: Adnan Kastrati

October 24, 2012

Presentation TCT 2012

Should Aspiration Thrombectomy Be First Line Therapy?

Presenter: Sameer Mehta

October 24, 2012

Advertisement

Is Intraaortic Balloon Counterpulsation Really Useful in Cardiogenic Shock? Results of the IABP-SHOCK II Trial

Hypothermia in STEMI: When, to Whom, and How? (Cardiac Arrest, Cardiogenic Shock, Stable STEMI)

Glycoprotein IIb/IIIa Inhibitors in the Era of Bivalirudin and New Oral Antiplatelet Agents: Is Intracoronary Application the Standard of Choice?

Geographic Disparities in the Management of ACS in the United States: Making the Case for Standardization of Care

Debate: Yes to Routine Thrombectomy in STEMI: New Trials Are Not Needed!

Debate: Transradial Access Should Be the Default Access Site in STEMI Patients!

Debate: Transfemoral Access Should Be the Default Access Site in STEMI Patients!

Debate: Primary PCI Is the Default Reperfusion Method Irrespective of Time to Transfer!

Debate: No to Routine Thrombectomy in STEMI: Still Yet to Be Demonstrated!

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

A Prospective, Randomized Trial of Post-Conditioning in Patients with ST-Segment Elevation Myocardial Infarction

TRILOGY ACS Angiographic Cohort: A Prospective, Randomized Trial of Prasugrel vs. Clopidogrel in Patients with Non-ST-Segment Elevation ACS Who Are Medically Managed After...

To Stage or Not to Stage?

The Potential of Otamixaban as a Procedural Anticoagulant

Systemic Hypothermia: For Hospital Arrest and Myocardial Infarction?

Strategies for the ACS Patient with Chronic Atrial Fibrillation

STEMI Cocktails

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Should Aspiration Thrombectomy Be First Line Therapy?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content